Elevation Behavioral Health is a luxury mental health treatment center fully dedicated to the most innovative treatment of mental health disorders and dual diagnosis. Our expert psychiatric team provides highly effective, compassionate treatment for a wide array of mental health disorders.
Elevation Behavioral Health
This report presents the aggregated results of three standardized outcome measures collected through Kipu: the PHQ-9 (Patient Health Questionnaire-9), the GAD-7 (Generalized Anxiety Disorder-7), and the PCL-5 (PTSD Checklist for DSM-5). These tools are utilized at Elevation Behavioral Health to assess and track the severity of depression, anxiety, and post-traumatic stress symptoms among clients in our residential program.
The primary objective of this analysis is to assess clinical effectiveness, monitor symptom changes over time, and inform treatment planning at both the individual and programmatic levels.
By reviewing trends in client scores, we aim to:
The data reflects the collective outcomes of clients actively engaged in residential treatment between January and June 2025. Overall, the analysis supports a clear trajectory of symptom reduction across all three measures, highlighting the therapeutic value of our current interventions. These insights will continue to guide the refinement of clinical practices and enhance the quality of support we offer to our clients.
DATA PER RTC PROGRAM: Residential Program
The baseline average baseline PHQ-9 score among clients was 18.09, which falls within the severe depression range. By week 4, the average score dropped significantly to 8.73, reflecting a 51.74% reduction and a transition from severe to mild depression. This decline continued throughout the data collection period, reaching an average of 3, indicating minimal depressive symptoms among clients who completed the full course of treatment.
In addition to symptom reduction, clients also reported improvements in daily functioning. The PHQ-9 impairment item, which assesses how difficult symptoms make it to function in work, home, and relationships, decreased from 2.19 (interpreted as “very difficult”) to 1.0 by week 4 (“somewhat difficult”). Clients who remained in treatment for 4 or more weeks reported a final average impairment score of 0, suggesting no significant functional interference by the end of treatment.
Data strongly suggests that the interventions provided were effective in reducing depressive symptoms and restoring emotional and behavioral health.
At baseline, the average GAD-7 score for clients at Kanan was 14, indicating moderate to severe levels of anxiety. By week 4, the average score had significantly decreased to 7.5, reflecting a 46.4% reduction in reported anxiety symptoms. This score also marks a clinical shift from moderate/severe anxiety to the mild range.
Among clients who completed at least 4 weeks of treatment, scores continued to improve beyond week 4 data collection, with many reaching the minimal anxiety range (GAD-7 scores of 5 or below) by the end of their data collection.
At baseline, the average PCL-5 total score was 43.97, indicating a clinically significant level of PTSD symptoms. By week 4, the average had dropped to 27.67, reflecting a 37.1% reduction in PTSD severity. This substantial drop suggests meaningful clinical improvement within the first month of treatment.
DATA PER RTC PROGRAM: PHP-IOP Programs Data
Depression baseline of clients (PHQ-9) drops from (12.75) to week 4 (11.29) indicates symptom improvement early in treatment. However, the rise in PHQ-9 scores closer to discharge for longer-stay clients suggests an increase in depressive symptoms before leaving the program.
The initial small drop from baseline to week 4 (10.9 to 10) shows some early reduction in anxiety symptoms. However, the later increase suggests anxiety may worsen or fluctuate over the course of treatment, especially closer to discharge.
The rise in trauma scores from baseline to week 4, continuing upward, indicates that trauma symptoms intensified rather than improved during early to mid-treatment phases.
Being “triggered to go home” suggests that returning to their usual environment might provoke stress, anxiety, or depressive symptoms. Clients may feel uncertain, unsafe, or overwhelmed about reintegrating into their home or community settings.
Discharge can represent a loss of structure, daily therapeutic support, and a sense of safety, which might temporarily increase distress or depressive symptoms.
Our Outcomes
Conclusion
Residential programs demonstrated significant improvements across depression, anxiety, and trauma symptoms during treatment.
Residential clients experienced a sustained decline in symptom severity—PHQ-9 scores dropped 51.74% by week 4, and GAD-7 decreased by 46.4%.
Trauma symptom reduction was also 37.1%
Residential data reflects a faster and more robust clinical response, suggesting variations in treatment effectiveness, client characteristics, or program intensity that merit further exploration to verify program’s effectiveness.
Action Plan: Questions for further analysis:
Our Outcomes
PHP/IOP
On the other hand, clients in the PHP/IOP program showed modest early improvements in depression and anxiety symptoms by week 4; however, trauma symptoms tended to increase during this period. Like residential clients, many experienced heightened distress and symptom fluctuations closer to discharge, related to anxiety about returning home and loss of structured support.
Action plan: These findings highlight the need for targeted discharge planning, for example with the support of a case manager; and ongoing outpatient support to help clients manage transitional stressors and maintain treatment gains after completing PHP/IOP care.
Post-discharge increases in symptom scores among PHP clients may, in part, reflect external stressors (particularly housing instability or uncertainty) which can negatively impact well-being and influence clients’ responses. These findings highlight the importance of addressing social determinants of health, such as housing security in discharge planning, to support sustained recovery and prevent regression.
Due to the launch and ongoing operations of a new residential treatment center (RTC), Elevation Behavioral Health will be discontinuing its PHP and IOP programs as of July 2025.
Ready to Take the First Step?
These outcomes underscore the power of a holistic, individualized approach to mental health treatment. Our multidisciplinary team of clinicians, therapists, and support staff work collaboratively to address the root causes of mental health challenges while equipping patients with the tools needed for long-term success. By choosing Elevation Behavioral Health, patients are not just receiving treatment—they are embarking on a transformative journey toward improved mental health and a brighter future.
Contact us today to learn more about our Residential Treatment Program and how we can help you or your loved one experience lasting change.